Navigation Links
Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition
Date:7/15/2014

NEW YORK, July 15, 2014 /PRNewswire-iReach/ -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to introduce "Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition," a series of new global surveys designed to identify major business opportunities emerging in the diagnostics market during the next five years.  The reports examine key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; review over 400 current and emerging assays; analyze potential applications of innovative diagnostic technologies; forecast volume and sales by assay, market segment, and country; provide test volume estimates by method; profile leading players and potential market entrants; and suggest alternative business expansion strategies for suppliers.

To review these new reports, please visit http://www.vpgmarketresearch.com/Diagnostics-Market-in-Transition.html

- Winning Strategies in Molecular Diagnostics 
Integrating New Technology Planning with Business and Corporate Strategies
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Infectious Disease Testing:  Rapidly Growing and Challenging Market Facing Suppliers
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Cancer Diagnostics:  Market on the Verge of Explosion
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence    

- Immunodiagnostics: Spot Fast-Growing Market Segments
Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

- Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges
Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

- Coagulation Testing in Transition
Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

- 2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market
France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

These thought-provoking reports are designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.

The studies offer expert analyses, strategic insights and granular data, such as supplier shares and sales forecasts for over 400 diagnostic tests by country and market segment.

The reports are available by region, country, section, market segment, individual test, and can be custom-tailored to specific information needs and budget.

The global diagnostic market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances will radically change the global diagnostics market during the next five years.  New specific and sensitive markers will be increasingly used on automated instrumentation.  Diagnostic testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the diagnostic testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

To review these and related IVD reports, please visit http://www.vpgmarketresearch.com/In-Vitro-Diagnostics

For further details or questions regarding these reports, please contact:

Robert Fisher
Robert@vpgcorp.com 
+1 212 564 2838

www.VPGMarketResearch.com

www.LeadingMarketResearch.com

Media Contact: Robert Fisher, Venture Planning Group, 212-564-2838, robert@vpgcorp.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Venture Planning Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... As part of the nationwide Days ... the victims of the Holocaust and Nazi persecution, Center for Medicine after the ... on its CMATH Champions trip to Germany and Poland next week. , The Fourth ...
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer dental ... 1,961 people during the April 22-23 event at the San Mateo Event Center. ... barriers to care, CDA Cares educates the public and policymakers about the importance of ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, a ... announced its popular products are now available for purchase on StackedNutrition.com, a popular ... use of premium natural ingredients in making all of its products. These ingredients ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading ... today announced that Kyle Allain has joined the company as Vice President and ... operations, including provider, payor and managed care solutions. , A seasoned executive ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of ... News website. , Rod has been at the forefront of Gardant since it was ... CEO, Rod has overseen the opening of more than 40 new senior living communities. ...
Breaking Medicine News(10 mins):